Comparison · NCT01705587-35bd4a02
Immediate Teriparatide vs Delayed Teriparatide: Radiologic Evidence of Healing
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Immediate Teriparatide vs Delayed Teriparatide: Radiologic Evidence of Healing. Trial comparisons, record NCT01705587-35bd4a02. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01705587-35bd4a02
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 1 | 0.566 | 1 | wilson | |
| Risk in group 2 | 1 | 0.51 | 1 | wilson | |
| Risk difference, group 1 minus group 2 | 0 | -0.434 | 0.49 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1 | 1 | 1 | log | |
| Odds ratio, group 1 over group 2 | log | a cell of the two-by-two table is zero | |||
| Number needed to treat | from the risk difference interval | the two groups' risks are equal |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Immediate Teriparatide | Open label teriparatide given immediately following surgical repair of fracture~teriparatide: 20 microgram once-daily subcutaneous injection | 5 | 5 | OG000 |
| Group 2 | Delayed Teriparatide | Open label teriparatide given six months following surgical repair of fracture~teriparatide: 20 microgram once-daily subcutaneous injection | 4 | 4 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Radiologic Evidence of Healing
- Description
- Number of participants with persistence of alignment as determined by a radiologist.
- Time frame
- at 10 weeks for immediate teriparatide group
- Population
Based on orthopedic surgeons' assessment, x-rays were not deemed necessary in over 30% of patients at week 10. Results presented are for those who had x-rays at 10 weeks to assess persistence of alignment for safety purposes.
Source ClinicalTrials.gov
Trial
- Title
- Fracture (FX) Improvement With Teriparatide: FiX-IT Study
- NCT number
- NCT01705587
- Phases
- PHASE4
- Conditions
- Osteoporosis, Atypical Femoral Fracture
- Interventions
- teriparatide
- Lead sponsor
- Susan L. Greenspan
- Results first posted
- 2017-12-12
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01705587?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01705587-35bd4a02